NCT06956248 Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE) Status RECRUITING Phase N/A
NCT06954077 A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors Status RECRUITING Phase PHASE1
NCT06952010 A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06949761 A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06939270 CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06932952 A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06911333 AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06895681 UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations Status NOT_YET_RECRUITING Phase N/A
NCT06895031 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS Status RECRUITING Phase PHASE2
NCT06883149 PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor Status RECRUITING Phase PHASE1
NCT06873659 SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06816108 A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors Status RECRUITING Phase PHASE1
NCT06810544 Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss Status RECRUITING Phase PHASE1/PHASE2
NCT06809114 FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06801002 Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies Status RECRUITING Phase PHASE1
NCT06797336 A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors Status RECRUITING Phase PHASE1